Código QR (código de barras bidimensional)

Post-neoadjuvant treatment of breast cancer

Achieving a pathologic complete response as a result of neoadjuvant treatment is associated with improved prognosis in breast cancer. The CREATE-X trial showed a significant survival improvement with capecitabine treatment of patients with residual invasive disease following neoadjuvant chemotherapy...

ver descrição completa

Na minha lista:
Principais autores: V. F. Semiglazov, M. A. Dzhelialova, S. S. Yerechshenko, E. T. Munaeva, R. S. Pesotsky, A. I. Tseluyko, A. S. Emelyanov, R. V. Donskikh, P. V. Krivorotko
Formato: Artigo
Idioma:Russo
Publicado em: Remedium Group LLC 2020-07-01
coleção:Медицинский совет
Assuntos:
breast cancer
post-neoadjuvant treatment
neoadjuvant systemic therapy
residual invasive tumor
potential biomarkers
Acesso em linha:https://www.med-sovet.pro/jour/article/view/5740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados